Apart from alterations in antigen expression, cancer cells may acquire resistance to CAR T cell therapy by dysregulating their apoptotic machinery, such as apoptotic pathway mediated by tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) (Torres-Collad and Jazirehi, 2018). Here, TNFSF10 is linked to cancer.